Relmada Therapeutics Inc (RLMD) Transcripts
Q3 2024 Relmada Therapeutics Inc Earnings Call Transcript
Nov 07, 2024
$3.26
(-4.12%)
Earnings
Q2 2024 Relmada Therapeutics Inc Earnings Call Transcript
Aug 07, 2024
$3.24
Earnings
Q1 2024 Relmada Therapeutics Inc Earnings Call Transcript
May 08, 2024
$3.83
(+0.26%)
Earnings
Q4 2023 Relmada Therapeutics Inc Earnings Call Transcript
Mar 19, 2024
$5.37
(-2.72%)
Earnings
Q3 2023 Relmada Therapeutics Inc Earnings Call Transcript
Nov 08, 2023
$3
(-1.64%)
Earnings
Q2 2023 Relmada Therapeutics Inc Earnings Call Transcript
Aug 08, 2023
$2.54
(-3.79%)
Earnings
Relmada Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Jun 14, 2023
Relmada Therapeutics Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Q1 2023 Relmada Therapeutics Inc Earnings Call Transcript
May 11, 2023
$3.17
(-3.06%)
Earnings
Q4 2022 Relmada Therapeutics Inc Earnings Call Transcript
Mar 23, 2023
$2.32
(-0.85%)
Earnings
Relmada Therapeutics Inc Top-line Results from Phase 3 RELIANCE I Trial for REL-1017 as an Adjunctive Treatment for Major Depressive Disorder - Corporate Call Transcript
Dec 07, 2022
Q3 2022 Relmada Therapeutics Inc Earnings Call Transcript
Nov 10, 2022
$5.84
(+1.39%)
Earnings
Q2 2022 Relmada Therapeutics Inc Earnings Call Transcript
Aug 11, 2022
$27.82
(-4.99%)
Earnings
Relmada Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022
Q1 2022 Relmada Therapeutics Inc Earnings Call Transcript
May 05, 2022
$22.4
(-7.70%)
Earnings
Q4 2021 Relmada Therapeutics Inc Earnings Call Transcript
Mar 23, 2022
$23.33
Earnings
Relmada Therapeutics Inc Results of Human Abuse Potential Study of REL-1017 vs. Ketamine - Corporate Call Transcript
Feb 23, 2022
Q3 2021 Relmada Therapeutics Inc Earnings Call Transcript
Nov 11, 2021
$25.66
(+3.22%)
Earnings
Relmada Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 10, 2021
Q2 2021 Relmada Therapeutics Inc Earnings Call Transcript
Aug 10, 2021
$23
(+1.28%)
Earnings
Relmada Therapeutics Inc REL-1017 Clinical Data Update Call Transcript
Jul 27, 2021
Q1 2021 Relmada Therapeutics Inc Earnings Call Transcript
May 12, 2021
$33.61
(-3.81%)
Earnings
Q4 2020 Relmada Therapeutics Inc Earnings Call Transcript
Mar 23, 2021
$34.34
(-3.40%)
Earnings